Close Menu

An article from yesterday's New York Times details the coming challenges in deriving food from genetically modified organisms, particularly here in the US, where so far there aren't a lot of guidelines on the subject. Getting FDA to "spell out the rules of the game," the article says, could be the encouragement investors need to get active in this area -- while others contend that such guidelines would scare the public by having the GMO term associated with this food.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.